Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 4/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | RAD52 | P43351 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11343369 | 0.93 | TDP1 (0.36) | TDP1CYP3A4TSHRESR1ESR2 | |
| SCHEMBL11346082 | 0.91 | KCNH3 (0.35) | TDP1CYP3A4TSHRESR1ESR2 | |
| SCHEMBL11333065 | 0.91 | KCNH3 (0.35) | TDP1CYP3A4TSHRESR1ESR2 | |
| SCHEMBL11336348 | 0.91 | KCNH3 (0.35) | TDP1CYP3A4TSHRESR1ESR2 | |
| SCHEMBL11343073 | 0.91 | KCNH3 (0.35) | TDP1CYP3A4TSHRESR1ESR2 | |
| SCHEMBL11336836 | 0.91 | KCNH3 (0.35) | TDP1CYP3A4TSHRESR1ESR2 | |
| SCHEMBL11340576 | 0.91 | KCNH3 (0.35) | TDP1CYP3A4TSHRESR1ESR2 | |
| Ethylene Glycol SCHEMBL7950018 | 0.91 | TDP1 (0.38) | TDP1CYP3A4TSHRESR1ESR2 | |
| SCHEMBL505809 | 0.85 | TDP1 (0.41) | TDP1CYP3A4TSHRESR1ESR2 | |
| SCHEMBL35092 | 0.85 | CYP3A4 (0.45) | TDP1CYP3A4ESR1ESR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115819732-A | Active polymerization cyclic palladium catalyst and preparation method and application thereof | 合肥工业大学 | 2023-03-21 | — | — | CN | claimed |
| US-8080667-B2 | Electroluminescent metal complexes with triazoles and benzotriazoles | BASF SE (DE) | 2011-12-20 | — | — | US | claimed |
| US-7820828-B2 | Electroluminescent metal complexes with triazoles and benzotriazoles | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-10-26 | — | — | US | claimed |
| US-20100244014-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES AND BENZOTRIAZOLES | UDC IRELAND LIMITED (IE) | 2010-09-30 | — | — | US | claimed |
| CN-115819732-A | Active polymerization cyclic palladium catalyst and preparation method and application thereof | 合肥工业大学 | 2023-03-21 | — | — | CN | disclosed |
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2019-01-01 | — | — | US | disclosed |
| EP-1893718-B1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES AND BENOTRIAZOLES | UDC IRELAND LTD (IE) | 2018-10-03 | — | — | EP | disclosed |
| EP-2802594-B1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| EP-1966343-B1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | UDC IRELAND LTD (IE) | 2017-02-16 | — | — | US | disclosed |
| US-9472762-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2016-10-18 | — | — | US | disclosed |
| US-9362510-B2 | Electroluminescent metal complexes with benzotriazoles | BASF SE (DE) | 2016-06-07 | — | — | US | disclosed |
| US-4687874-A | Selective hydroformylation process using alkyl diaryl phosphine rhodium carbonyl hydride catalysts | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1987-08-18 | — | — | US | disclosed |
| US-4668809-A | ALKYL DIARYLPHOSPHINE RHODIUM CARBONYL HYDRIDES, HYDROFORMYLATION, OLEFINS | EXXON RESEARCH AND ENGINEERING (US) | 1987-05-26 | — | — | US | disclosed |
| US-4595753-A | Nitrogen heterocycle substituted | EXXON RESEARCH AND ENGINEERING CO. (US) | 1986-06-17 | — | — | US | disclosed |
| EP-0024091-B1 | HYDROFORMYLATION PROCESS AND NOVEL TRANSITION METAL CATALYSTS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1985-04-03 | — | — | EP | disclosed |
| US-4296042-A | Preparation of unsaturated aliphatic insect pheromones using cyclic phosphonium ylids | SYNTEX (U.S.A.) INC. (US) | 1981-10-20 | — | — | US | disclosed |
| EP-0024091-A4 | HYDROFORMYLATION PROCESS AND NOVEL TRANSITION METAL CATALYSTS. | EXXON RESEARCH ENGINEERING CO (US) | 1981-07-16 | — | — | EP | disclosed |
| EP-0024091-A1 | HYDROFORMYLATION PROCESS AND NOVEL TRANSITION METAL CATALYSTS. | EXXON RESEARCH ENGINEERING CO (US) | 1981-02-25 | — | — | EP | disclosed |
| WO-1980001690-A1 | CARBONYLATION PROCESS AND NOVEL TRANSITION METAL CATALYSTS | EXXON RESEARCH ENGINEERING CO (US) | 1980-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | NDUFS5, DDT, NDUFV2 | TDP1 2226/4885CYP3A4 152/4885TSHR 4431/4885 |
| US-20100244014-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES AND BENZOTRIAZOLES | OCIAD1, OXA1L, OCIAD2 | TDP1 2004/4885CYP3A4 243/4885TSHR 1510/4885 |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | NDUFS2, OCIAD2, NDUFS3 | TDP1 3871/4885CYP3A4 470/4885TSHR 4730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.